Efficacy of Fibrin Sealant to Reduce the Amount of Post-thyroidectomy Drain
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT01126060 |
|
Recruitment Status :
Completed
First Posted : May 19, 2010
Results First Posted : December 19, 2011
Last Update Posted : December 19, 2011
|
- Study Details
- Tabular View
- Study Results
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Thyroid Carcinoma Thyroidectomy | Drug: Usage of Fibrin sealant Procedure: Thyroidectomy | Phase 3 |
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 78 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Masking: | Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor) |
| Primary Purpose: | Treatment |
| Official Title: | Efficacy of Fibrin Sealant to Reduce the Amount of Postoperative Drain in Patients With Harmonic Scalpel-assisted Total Thyroidectomy With Anterior Compartment Neck Dissections |
| Study Start Date : | February 2010 |
| Actual Primary Completion Date : | January 2011 |
| Actual Study Completion Date : | January 2011 |
| Arm | Intervention/treatment |
|---|---|
|
Active Comparator: Fibrin sealant
usage of fibrin sealant after surgery
|
Drug: Usage of Fibrin sealant
Usage of 1 vial of fibrin sealant after hemostasis in total thyroidectomy with anterior compartment neck dissection Procedure: Thyroidectomy surgical removal of bilateral thyroid glands |
|
No Intervention: Control
No usage of fibrin sealant
|
Procedure: Thyroidectomy
surgical removal of bilateral thyroid glands |
- Postoperative Drainage Amount [ Time Frame: serial measurement from 1day to 4day after surgery ]method : measurement of drainage fluids from negative suction system every 8 hr until daily total amount reduces under 20mL
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 20 Years to 80 Years (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- proven thyroid carcinoma
- Thyroidectomy with anterior compartment neck dissection
Exclusion Criteria:
- No use of harmonic scalpel during surgery
- coagulation abnormality
- refuse to participate
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01126060
| Korea, Republic of | |
| Samsung Medical Center | |
| Seoul, Korea, Republic of, 135-710 | |
| Responsible Party: | Man Ki Chung/Assistant professor, Samsung Medical Center |
| ClinicalTrials.gov Identifier: | NCT01126060 |
| Other Study ID Numbers: |
2009-12-093 |
| First Posted: | May 19, 2010 Key Record Dates |
| Results First Posted: | December 19, 2011 |
| Last Update Posted: | December 19, 2011 |
| Last Verified: | November 2011 |
|
Neck dissection |
|
Thyroid Neoplasms Endocrine Gland Neoplasms Neoplasms by Site Neoplasms Head and Neck Neoplasms |
Endocrine System Diseases Thyroid Diseases Fibrin Tissue Adhesive Hemostatics Coagulants |

